The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Claforan Powder for Solution for Injection 500mg

500 milligram(s) Powder for solution for injection

Sanofi-Aventis Ireland Limited T/A SANOFIPA0540/037/002

Main Information

Trade NameClaforan Powder for Solution for Injection 500mg
Active SubstancesCefotaxime sodium
Strength500 milligram(s)
Dosage FormPowder for solution for injection
Licence HolderSanofi-Aventis Ireland Limited T/A SANOFI
Licence NumberPA0540/037/002

Group Information

ATC CodeJ01DD Third-generation cephalosporins
J01DD01 cefotaxime

Status

Authorised/WithdrawnAuthorised
Licence Issued13/05/1981
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back